BiotechTube
Home/Kissei Pharmaceutical/Tatsuya Higashi
TH

Tatsuya Higashi

Director, Managing Executive Officer

Kissei Pharmaceutical

Therapeutic Areas

UrologyNephrologyMetabolic DiseasesGastroenterologyPain

Kissei Pharmaceutical Pipeline

DrugIndicationPhase
Uprifosbuvir (K-579)Erectile DysfunctionApproved
KRP-297 (Mirogabalin)Diabetic Peripheral Neuropathic Pain (DPNP)Phase III
KRP-203 (Amiselimod)Ulcerative ColitisPhase II
K-878Constipation-predominant Irritable Bowel Syndrome (IBS-C)Phase II
K-117Chronic Kidney Disease with Renal AnemiaPhase II
K-321Post-cataract surgery inflammation & painPhase II

Leadership Team at Kissei Pharmaceutical

MS
Masanori Suzuki
Representative Director, President & CEO
KA
Kazunori Araki
Director, Senior Managing Executive Officer
HY
Hiroshi Yamada
Director, Senior Managing Executive Officer
YI
Yoshinori Ishihara
Director, Managing Executive Officer
TM
Takeshi Matsuzaki
Director, Managing Executive Officer
YO
Yukihiro Ochi
Director
YK
Yoshihiko Katsuyama
Director
YO
Yoshihiro Oyamada
Director
YK
Yoshihiko Kawamura
Standing Corporate Auditor
MO
Masahiko Oka
Corporate Auditor
View full Kissei Pharmaceutical profile